Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study - Université de Lorraine Access content directly
Journal Articles The Lancet Neurology Year : 2010

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study

Dates and versions

hal-02640359 , version 1 (28-05-2020)

Identifiers

Cite

Samantha Jilek, Emilie Jaquiéry, Hans Hirsch, Andreas Lysandropoulos, Mathieu Canales, et al.. Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study. The Lancet Neurology, 2010, 9 (3), pp.264-272. ⟨10.1016/S1474-4422(10)70006-5⟩. ⟨hal-02640359⟩
12 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More